These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34878693)

  • 1. Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
    Nakatani K; Serada S; Fujimoto M; Obata K; Ohkawara T; Sasabe E; Yamamoto T; Naka T
    J Oral Pathol Med; 2022 Feb; 51(2):126-133. PubMed ID: 34878693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
    Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.
    Kajiyama T; Serada S; Fujimoto M; Ohkawara T; Komori M; Hyodo M; Naka T
    Anticancer Res; 2022 Jul; 42(7):3361-3372. PubMed ID: 35790291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Ohkawara T; Hiramatsu K; Nishida T; Hirota S; Saito Y; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Hanasaki K; Kishimoto T; Mori M; Doki Y; Naka T
    Gastric Cancer; 2018 Nov; 21(6):968-976. PubMed ID: 29623544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
    Tan J; Xiang L; Xu G
    IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
    Yu SJ; Long ZW
    Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop.
    Xiao C; Zhang W; Hua M; Chen H; Yang B; Wang Y; Yang Q
    Cell Mol Biol Lett; 2022 May; 27(1):36. PubMed ID: 35562668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
    Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
    Pan LN; Sun YR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of PRDM5 promotes cell proliferation by regulating JAK/STAT signaling pathway through SOCS1 in human lung adenocarcinoma.
    Ren Y; Wang Y; Fang L; Ma M; Ge L; Su C; Xin L; He J; Yang J; Liu X
    Cancer Med; 2023 Feb; 12(4):4568-4578. PubMed ID: 36127737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3.
    Wu Y; Chen L; Feng C; Wang T; He S; Zheng D; Lin L
    BMC Oral Health; 2023 Nov; 23(1):846. PubMed ID: 37946196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
    Yang JG; Lu R; Ye XJ; Zhang J; Tan YQ; Zhou G
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.
    Weng J; Ren Q; Li Z; Wang W; Guan J
    J Oral Pathol Med; 2021 Oct; 50(9):902-910. PubMed ID: 34392586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma.
    Liu L; Li W; Wei X; Cui Q; Lou W; Wang G; Hu X; Qian C
    Gene Ther; 2013 Jan; 20(1):84-92. PubMed ID: 22318090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Hiramatsu K; Ohkawara T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Kishimoto T; Mori M; Doki Y; Naka T
    Cancer Res; 2017 Dec; 77(24):6975-6986. PubMed ID: 29042418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.
    Baus D; Pfitzner E
    Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis.
    Ukey S; Jain A; Dwivedi S; Vishnoi JR; Chugh A; Purohit P; Pareek P; Elhence P; Misra S; Sharma P
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S551-S559. PubMed ID: 38384018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.